SCNI (Scinai Immunotherapeutics Ltd. American Depositary Shares) Stock Analysis - Analyst Ratings

Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI) is a publicly traded Healthcare sector company. As of May 20, 2026, SCNI trades at $0.50 with a market cap of $2.22M and a P/E ratio of 0.00. SCNI moved -5.14% today. Year to date, SCNI is -30.35%; over the trailing twelve months it is -81.98%. Its 52-week range spans $0.45 to $6.18. Rallies surfaces SCNI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate SCNI?

The average price target is $0.00.

SCNI Key Metrics

Key financial metrics for SCNI
MetricValue
Price$0.50
Market Cap$2.22M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$6.18
52-Week Low$0.45
Volume617.09K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

SCNI Analyst Consensus

SCNI analyst coverage data. Average price target: $0.00.

Latest SCNI News

Recent SCNI Insider Trades

  • BEATY ELWIN M bought 80.00K (~$5.20K) on Dec 14, 2007.
  • BEATY ELAINE E bought 80.00K (~$5.20K) on Dec 14, 2007.
  • BEATY ELWIN M sold 80.00K (~$5.20K) on Dec 14, 2007.

Common questions about SCNI

What do analysts rate SCNI?
The average price target is $0.00.
Does Rallies show SCNI price targets?
Yes. Rallies tracks SCNI analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is SCNI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SCNI. It does not provide personalized investment advice.
SCNI

SCNI